Publications by authors named "Barry Kerr"

Claim this Profile
H
Health Information on Breast Cancer Surgery on YouTube®.
Louise Cousins, Lynn Darragh, Barry Kerr

Clin Breast Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Drugs to Probe the Variability of Trans-Epithelial Airway Resistance.
Kendra Tosoni, Diane Cassidy, Barry Kerr, Stephen C Land, Anil Mehta

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties.
Vikas K Bhat, Barry D Kerr, Peter R Flatt, Victor A Gault

Biochem Pharmacol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity.
Victor A Gault, Barry D Kerr, Patrick Harriott, Peter R Flatt

Clin Sci (Lond)· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptide.
Barry D Kerr, Anneliese J S Flatt, Peter R Flatt, Victor A Gault

Biochem Biophys Res Commun· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(D-Ser2)Oxm[mPEG-PAL]: a novel chemically modified analogue of oxyntomodulin with antihyperglycaemic, insulinotropic and anorexigenic actions.
Barry D Kerr, Peter R Flatt, Victor A Gault

Biochem Pharmacol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of gamma-glutamyl linker on DPP-IV resistance, duration of action and biological efficacy of acylated glucagon-like peptide-1.
Barry D Kerr, Peter R Flatt, Victor A Gault

Biochem Pharmacol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties.
Barry D Kerr, Nigel Irwin, Finbarr P M O'Harte, Clifford J Bailey, Peter R Flatt

Biochem Pharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged GIP receptor activation using stable mini-PEGylated GIP improves glucose homeostasis and beta-cell function in age-related glucose intolerance.
Barry D Kerr, Nigel Irwin, Peter R Flatt, Victor A Gault

Peptides· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-terminal mini-PEGylation of glucose-dependent insulinotropic polypeptide exhibits metabolic stability and improved glucose homeostasis in dietary-induced diabetes.
Victor A Gault, Barry D Kerr, Nigel Irwin, Peter R Flatt

Biochem Pharmacol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis